# Analyzing Female Trauma Exposed Responses to a Medication

> **NCT01814332** · PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 128 (actual)

## Conditions studied

- Stress Disorders, Post-traumatic

## Interventions

- **DRUG:** GSK561679
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01814332
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-01
- **Primary completion:** 2014-06-30
- **Final completion:** 2014-10-31
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2021-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01814332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01814332, "Analyzing Female Trauma Exposed Responses to a Medication". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01814332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*